$48.15
+2.47%
N/A+$1.16
Healthcare
Biotechnology
NASDAQ
Active Trading
CRISPR Therapeutics AG (CRSP) is a biotechnology firm dedicated to pioneering gene-based medicines for severe diseases. The company achieves this through its ...
C-Suite Executives
(0)The C-suite executives form a cohesive leadership team driving the company's financial strategy and innovation.
Key Team Members
No executives available for this level
Loading executive datasets...
Founder / CEO
7
C-Level
2
VP
0
Board
0
Director / Board
1
Other
0
Key Executives
| Name | Title | Compensation | Gender | Year Born | Status |
|---|---|---|---|---|---|
| Samarth Kulkarni | Chief Executive Officer & Chairman | USD 1,434,715 | — | 1978 | Active |
| Naimish Patel | Chief Medical Officer | USD 858,490 | — | 1972 | Active |
| James R. Kasinger | General Counsel & Secretary | USD 780,577 | 1972 | Active | |
| Raju Yashaswi Prasad | Chief Financial Officer | USD 779,557 | — | 1984 | Active |
| Shaun Foy | Co-Founder | — | — | Active | |
| Chad A. Cowan | Scientific Founder | — | — | 1972 | Active |
| Craig C. Mello | Co-Founder & Scientific Advisory Board Member | — | — | — | Active |
| Daniel G. Anderson | Co-Founder & Scientific Advisory Board Member | — | — | 1970 | Active |
| Emmanuelle Marie Charpentier | Co-Founder & Scientific Advisory Board Member | — | — | — | Active |
| Matthew Porteus | Co-Founder & Scientific Advisory Board Member | — | — | 1965 | Active |
Executive Compensation
(deduped by latest filing date per person-year)| Filing Date | Year | Name | Position | Level | Salary | Bonus | Stock Award | Option Award | Incentive | Other | Total |
|---|
Total Compensation Trend
Sum of disclosed compensation by year (USD million)
Key Roles Compensation Lines
Top founder/C-level executives over time (USD million)